like us on facebook connect with us on linkedin follow us on twitter November 09, 2022

Takeda Oncology

To learn more about Takeda Oncology's ALUNBRIG® (brigatinib)CLICK HERE.

Section Header Section Header Section Header

MSHO Featured Corporate Sponsor Assistance Programs

• Advanced Accelerator Applications PatientCONNECT
• Coherus Complete
• Deciphera AccessPoint

Details >
Section Header

WPS Oncology Related LCD Updates

November 2022

Stay current on retired and revised policies/articles

Details >

WPS Recent Oncology Related News

Part A, Part B and Part A/B News

• Submission Deadline for Phase 2 Section 131 Reviews
• WPS Closures
• Part B Immunosuppressant Drug (Part B-ID) Data in WPS Portal & IVR
• Medicare Hot Links to 2022 Final Rules and the WPS Fee Schedules

Details >
Section Header

CMS-Medicare

Recent Oncology Related Articles

• 2023 Medicare Physician Fee Schedule Final Rule
• Overview of the Quality Payment Program Policies
• 2023 CEHRT Requirements
• CY 2023 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Final Rule with Comment Period (CMS 1772-FC)
• ICD-10 Coordination and Maintenance Committee Meeting
• Recent Learn Resource & MedLearn Matters Articles

Details >

Recent RAC Monitor Article

This edition includes articles on

• CMS Fails Audit and is Told to “Get More Money!”
• The Catastrophic Effect of Natural Disasters on Medicare Audits

Details >
Section Header

BCBSM/BCN

Recent Oncology Related News

• Availity Portal Updates, Defects, and Workarounds 
• Tips to speed up the review process for AIM Prior Auth Requests
• Holiday office closings
• And more

Details >

BCBSM/BCN

Publications

• The Record
• BCN Provider News

Details >
Section Header

Current Payer Issue Tracking Page

Last Reviewed/Updated 11/9/22

• 10/11 Update on BCBSM Denials for Auth Exceeds Allowed

Details >

Resolved Payer Issues

Last Reviewed/Updated 11/9/22

• BCBSM Phesgo Issue and Denials for Auth Exceeds Allowed

Details >

Medicaid

Recent Oncology Related News

Medicaid Updates Include
• MSA Bulletin Updates
• Biller "B" Aware Notices

Details >

Newsletters of Interest

• Aetna OfficeLink Updates
• Cigna
• HAP
• Humana YourPractice
• UHC Network News

Details >

Priority Health Update

• 2 codes no longer require prior authorization
• 30-day pre-claim appeal deadline
• 2023 commercial & Medicare product information
• And more

Details >
Section Header

Recent Oncology Related FDA Approvals and Expanded Indications

• Regeneron Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy

Details >
Section Header Section Header